Status:
RECRUITING
Thai PainPREDICT Validation Study
Lead Sponsor:
Chulalongkorn University
Conditions:
Painful Diabetic Neuropathy (PDN)
Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Painful diabetic neuropathy (PDN) is one of the most common and disabling complications of diabetes mellitus, substantially affecting quality of life, daily functioning, and health system burden. Earl...
Detailed Description
This study aims to translate, culturally adapt, and validate the PainPREDICT questionnaire for the Thai population, and to integrate it into a mobile application for use in both clinical and community...
Eligibility Criteria
Inclusion
- Adults aged 18 years or older.
- Diagnosed with type 1 diabetes mellitus or type 2 diabetes mellitus.
- Able to communicate in Thai.
- Willing and able to provide written informed consent.
Exclusion
- Presence of neuropathy due to other causes (e.g., alcohol, chemotherapy, HIV, other systemic diseases).
- Significant cognitive impairment or neurological conditions that prevent comprehension of the questionnaire.
- Severe psychiatric illness that interferes with study participation.
Key Trial Info
Start Date :
August 28 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
277 Patients enrolled
Trial Details
Trial ID
NCT07195045
Start Date
August 28 2025
End Date
December 31 2027
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Chulalongkorn Memorial hospital, The Thai Red Cross Society
Pathum Wan, Bangkok, Thailand, 10330